Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-07-08

FDA Approved: ERLOTINIB HYDROCHLORIDE — Original Application (Alembic Pharmaceuticals Limited)

View source ↗

Summary

FDA approved Alembic Pharmaceuticals Limited's Erlotinib Hydrochloride original application (ANDA214719), authorizing a generic Erlotinib hydrochloride product …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Erlotinib hydrochloride (Erlotinib)

Snippet

ORIG AP for ERLOTINIB HYDROCHLORIDE (ERLOTINIB HYDROCHLORIDE)